Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2004; 92(03): 666-667
DOI: 10.1055/s-0037-1613738
DOI: 10.1055/s-0037-1613738
Case Report
A case of acquired von Willebrand syndrome successfully treated with recombinant Factor VIIa during thyroidectomy
Authors
Further Information
Publication History
Received
06 April 2004
Accepted after revision
20 June 2004
Publication Date:
15 December 2017 (online)
-
References
- 1 Veyradier A, Jenkins SPC, Resinous E. et al. Acquired von Willebrand syndrome: From pathophysiology to management. Thromb Haemost 2000; 84: 175-82.
- 2 Budde U, Bergmann F, Michiels JJ. Acquired von Willebrand syndrome. Experience from 2 years in a single laboratory compared with data from the literature and an International Registry. Semin Thromb Hemost 2002; 28: 227-37.
- 3 Budde U. et al. Subunit Composition of plasma von Willebrand factor in patients with the mye-loproliferative syndrome. Blood 1986; 68: 1213-7.
- 4 Federica AB, Rand JH, Bucciarelli P. et al. Acquired von Willebrand syndrome. Data from an International Registry. Thromb Haemost 2000; 84: 345-9.
- 5 Zimmerman TS. et al. Determination of the von Willebrand disease antigen in plasma by quantitative immuno-electrophoresis. J Lab Clin Med 1975; 86: 152-9.
- 6 Ruggeri ZM, Zimmerman T. Variant von Willebrand disease. J Clin Invest 1980; 65: 1318-25.
- 7 Montgomery RR, Zimmerman TS. Von Willebrand’s Disease antigen II. J Clin Invest 1978; 61: 1498-1507.
- 8 Simone JV, Vanderheiden J, Abildgaard CF. A semiautomatic one-stage Factor VIII assay with a commercial prepared standard. J Lab Clin Med 1967; 69: 706-12.
- 9 Shapiro AD, Gilchirst GS, Hoots WK. et al. Prospective, randomised trial of two doses of rFVIIa (Novoseven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 1998; 80: 773-8.
- 10 Kumar S, Pruthi RK, Nichols WL. Acquired von Willebrand’s Syndrome: A single institution experience. Am J Hematol 2003; 72: 243-7.
- 11 Federici AB, Stabile F, Castaman G. et al. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. Blood 1998; 92: 2707-11.
- 12 Bussel JB. Intravenous treatment with gammaglobulin in adults with immune thrombocytopenic purpura: Review of the literature. Vox Sang 1987; 52: 206-11.
- 13 Friederich PW, Philip FW, Wever PC. et al. Successful treatment with recombinant Factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand Disease. Am J Hematol 2001; 66: 292-4.
- 14 Hoffmann M, Monroe III DM. The action of high dose factor VIIa (FVIIa) in a cell-based model of hemostasis. Semin Hematol 2001; 38: 6-9.